Finding diamonds in the rubble

Experimental Neurology

Volumn 205, Issue 1, 2007, Pages 1-4

  Cha, Jang Ho J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; DIAMOND; DNA; DOPAMINE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN SUBUNIT; RNA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; CRANIAL NERVE; DEGENERATIVE DISEASE; DNA FINGERPRINTING; DNA MICROARRAY; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUNTINGTON CHOREA; MITOSIS; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN ANALYSIS; RNA DEGRADATION; SHY DRAGER SYNDROME; TRAUMATIC BRAIN INJURY;

EID: 34247256038     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.02.003     Document Type: Note

References (25)

1. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., and Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2173-2178
2. Bossy-Wetzel E., Schwarzenbacher R., and Lipton S.A. Molecular pathways to neurodegeneration. Nat. Med. 10 (2004) S2-S9 (Suppl.)
3. Brain S.D., and Cox H.M. Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br. J. Pharmacol. 147 Suppl. 1 (2006) S202-S211
4. Cannizzaro C., Tel B.C., Rose S., Zeng B.Y., and Jenner P. Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease. Brain Res. Mol. Brain Res. 110 (2003) 169-176
5. Dangond F., Hwang D., Camelo S., Pasinelli P., Frosch M.P., Stephanopoulos G., Brown Jr. R.H., and Gullans S.R. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol. Genomics 16 (2004) 229-239
6. Farrer M.J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat. Rev., Genet. 7 (2006) 306-318
7. Fernagut P.O., and Chesselet M.F. Alpha-synuclein and transgenic mouse models. Neurobiol. Dis. 17 (2004) 123-130
8. Goedert M., and Jakes R. Mutations causing neurodegenerative tauopathies. Biochim. Biophys. Acta 1739 (2005) 240-250
9. Grunblatt E., Mandel S., Jacob-Hirsch J., Zeligson S., Amariglo N., Rechavi G., Li J., Ravid R., Roggendorf W., Riederer P., and Youdim M.B. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J. Neural Transm. 111 (2004) 1543-1573
10. Hauser M.A., Li Y.J., Xu H., Noureddine M.A., Shao Y.S., Gullans S.R., Scherzer C.R., Jensen R.V., McLaurin A.C., Gibson J.R., Scott B.L., Jewett R.M., Stenger J.E., Schmechel D.E., Hulette C.M., and Vance J.M. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch. Neurol. 62 (2005) 917-921
11. Hodges A., Strand A.D., Aragaki A.K., Kuhn A., Sengstag T., Hughes G., Elliston L.A., Hartog C., Goldstein D.R., Thu D., Hollingsworth Z.R., Collin F., Synek B., Holmans P.A., Young A.B., Wexler N.S., Delorenzi M., Kooperberg C., Augood S.J., Faull R.L., Olson J.M., Jones L., and Luthi-Carter R. Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 15 (2006) 965-977
12. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is unstable in Huntington's disease chromosomes. Cell 72 (1993) 971-983
13. Kosik K.S., and Shimura H. Phosphorylated tau and the neurodegenerative foldopathies. Biochim. Biophys. Acta 1739 (2005) 298-310
14. Luthi-Carter R., Strand A., Peters N.L., Solano S.M., Hollingsworth Z.R., Menon A.S., Frey A.S., Spektor B.S., Penney E.B., Schilling G., Ross C.A., Borchelt D.R., Tapscott S.J., Young A.B., Cha J.-H.J., and Olson J.M. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9 (2000) 1259-1271
15. Luthi-Carter R., Apostol B.L., Dunah A.W., DeJohn M.M., Farrell L.A., Bates G.P., Young A.B., Standaert D.G., Thompson L.M., and Cha J.-H.J. Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA expression levels, protein abundance, interacting proteins and phosphorylation. Neurobiol. Dis. 14 (2003) 624-636
16. Miller R.M., Callahan L.M., Casaceli C., Chen L., Kiser G.L., Chui B., Kaysser-Kranich T.M., Sendera T.J., Palaniappan C., and Federoff H.J. Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J. Neurosci. 24 (2004) 7445-7454
17. Muchowski P.J., and Wacker J.L. Modulation of neurodegeneration by molecular chaperones. Nat. Rev., Neurosci. 6 (2005) 11-22
18. Nicholson S.L., and Brotchie J.M. 5-Hydroxytryptamine (5-HT, serotonin) and Parkinson's disease-Opportunities for novel therapeutics to reduce the problems of levodopa therapy. Eur. J. Neurol. 9 Suppl 3 (2002) 1-6
19. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Brown R.H., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. (published erratum appears in Nature 1993 Jul 22;364(6435):362). Nature 362 (1993) 59-620 (see comments)
20. Roy S., Zhang B., Lee V.M., and Trojanowski J.Q. Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol. (Berl.) 109 (2005) 5-13
21. Stefanova N., Tison F., Reindl M., Poewe W., and Wenning G.K. Animal models of multiple system atrophy. Trends Neurosci. 28 (2005) 501-506
22. Steinman L., and Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat. Rev., Immunol. 3 (2003) 483-492
23. Tanzi R.E., and Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120 (2005) 545-555
24. Vogt I.R., Lees A.J., Evert B.O., Klockgether T., Bonin M., and Wullner U. Transcriptional changes in multiple system atrophy and Parkinson's disease putamen. Exp. Neurol. 199 (2006) 465-478
25. Xiang W., Windl O., Wunsch G., Dugas M., Kohlmann A., Dierkes N., Westner I.M., and Kretzschmar H.A. Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J. Virol. 78 (2004) 11051-11060